To the reporters of the investigation, McGuire was more direct: the compound should not be used by humans. Eric Topol, director of the Scripps Research Translational Institute, was even more straightforward than McGuire: None of [the experimental compounds] are proven. He called it extraordinary that gray market human use was occurring in the absence of adequate clinical trials
What the shortage removal means for compounding Once tirzepatide left the shortage list, the legal basis for routine compounding of tirzepatide copies evaporated
Detailed information can be found in the Methods
Bounous G et al
For those interested in addressing cosmetic changes, procedures like labia puffing with dermal fillers or fat transfer may help restore fullness
Book consultation Future Retatrutide Pages Should Be Added Here As GoalBMI Wellness publishes additional resources covering Retatrutide clinical trials, cost, insurance coverage, GLP-3 research, injection education, comparisons with Semaglutide, and long-term outcomes, those pages should be added to this Learning Center and linked naturally throughout the article